Detalhe da pesquisa
1.
Baricitinib treatment rapidly improves the four signs of atopic dermatitis assessed by Eczema Area and Severity Index (EASI) clinical subscores.
J Eur Acad Dermatol Venereol
; 38(4): 695-702, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38041556
2.
Unbound Corneocyte Lipid Envelopes in 12R-Lipoxygenase Deficiency Support a Specific Role in Lipid-Protein Cross-Linking.
Am J Pathol
; 191(5): 921-929, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33607042
3.
Real-World Treatment Patterns and Treatment Benefits among Adult Patients with Atopic Dermatitis: Results from the Atopic Dermatitis Patient Satisfaction and Unmet Need Survey.
Acta Derm Venereol
; 102: adv00830, 2022 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36479885
4.
ABHD5 stimulates PNPLA1-mediated ω-O-acylceramide biosynthesis essential for a functional skin permeability barrier.
J Lipid Res
; 59(12): 2360-2367, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30361410
5.
Mice lacking lipid droplet-associated hydrolase, a gene linked to human prostate cancer, have normal cholesterol ester metabolism.
J Lipid Res
; 58(1): 226-235, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27836991
6.
Monoacylglycerol Lipases Act as Evolutionarily Conserved Regulators of Non-oxidative Ethanol Metabolism.
J Biol Chem
; 291(22): 11865-75, 2016 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-27036938
7.
G0/G1 Switch Gene 2 Regulates Cardiac Lipolysis.
J Biol Chem
; 290(43): 26141-50, 2015 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-26350455
8.
Baricitinib Improvement Across Regions in Atopic Dermatitis Patients with Baseline Body Surface Area up to 40% and Severe Itch.
Dermatol Ther (Heidelb)
; 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38777937
9.
Factors Predicting Quality of Life Impairment in Adult Patients with Atopic Dermatitis: Results from a Patient Survey and Machine Learning Analysis.
Dermatol Ther (Heidelb)
; 13(4): 981-995, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36862306
10.
Baricitinib provides rapid and sustained improvements in absolute EASI and SCORAD outcomes in adults with moderate-to-severe atopic dermatitis.
J Dermatolog Treat
; 34(1): 2216322, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37345379
11.
Integrated Safety Analysis on Skin Cancers among Patients with Psoriasis Receiving Ixekizumab in Clinical Trials.
Dermatol Ther (Heidelb)
; 13(8): 1773-1787, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37351831
12.
Treatment satisfaction of adult patients with moderate-to-severe atopic dermatitis treated with baricitinib in France, Germany, and the United Kingdom: results from a cross-sectional international patient survey.
J Dermatolog Treat
; 34(1): 2276047, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37965779
13.
Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications.
Adv Ther
; 40(4): 1867-1883, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36802049
14.
Safety of baricitinib for the treatment of atopic dermatitis over a median of 1.6 years and up to 3.9 years of treatment: an updated integrated analysis of eight clinical trials.
J Dermatolog Treat
; 34(1): 2161812, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36546346
15.
Baseline Body Surface Area and Itch Severity Define Response to Baricitinib in Patients with Moderate-to-Severe Atopic Dermatitis at Week 16.
Adv Ther
; 40(8): 3574-3587, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37332021
16.
G0/G1 switch gene-2 regulates human adipocyte lipolysis by affecting activity and localization of adipose triglyceride lipase.
J Lipid Res
; 53(11): 2307-17, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22891293
17.
A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19.
Adv Ther
; 39(11): 4910-4960, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36063279
18.
Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis.
Dermatol Ther (Heidelb)
; 12(6): 1481-1491, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35543919
19.
Burden of Moderate to Severe Atopic Dermatitis in Adults from France, Italy, and the UK: Patient-Reported Outcomes and Treatment Patterns.
Dermatol Ther (Heidelb)
; 12(8): 1947-1965, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35913548
20.
Correction to: A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19.
Adv Ther
; 40(9): 4114-4115, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37347406